Cargando…

Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report

BACKGROUND: Preterm birth accounts for about 12% of all pregnancies worldwide and is the leading cause of neonatal morbidity and mortality. In order to avoid premature birth and prolong gestational age, tocolytics are the first and the best choice. Ritodrine is the most commonly used tocolytic medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wen-Yu, Zhang, Jia-Rong, Xu, Xian-Ming, Ye, Tian-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855204/
https://www.ncbi.nlm.nih.gov/pubmed/35211573
http://dx.doi.org/10.12998/wjcc.v10.i4.1381
_version_ 1784653605574279168
author Liu, Wen-Yu
Zhang, Jia-Rong
Xu, Xian-Ming
Ye, Tian-Yi
author_facet Liu, Wen-Yu
Zhang, Jia-Rong
Xu, Xian-Ming
Ye, Tian-Yi
author_sort Liu, Wen-Yu
collection PubMed
description BACKGROUND: Preterm birth accounts for about 12% of all pregnancies worldwide and is the leading cause of neonatal morbidity and mortality. In order to avoid premature birth and prolong gestational age, tocolytics are the first and the best choice. Ritodrine is the most commonly used tocolytic medication. However, side effects such as pulmonary edema, hypokalemia, and hyperglycemia are known. Here we report a rare but serious side effect–toxic epidermal necrolysis (TEN)–caused by ritodrine. CASE SUMMARY: A woman (31 years, gravida 4, para 2) was hospitalized because of premature contractions at 27 + 6 wk of gestation. A skin rash with pruritus appeared at 32 + 3 wk of gestation after administration of ritodrine, indomethacin, and dexamethasone, and it spread throughout the whole body in 3 d, particularly the four limbs. After 11 d’ treatment, she was diagnosed with TEN. An emergency cesarean section was performed immediately to deliver the baby and intensive symptomatic treatment was promptly commenced after delivery. She recovered from the severe condition without any sequelae except for slight pigmentation after symptomatic treatment. CONCLUSION: When a skin rash appears during the administration of ritodrine, we are supposed to consider the risk of TEN.
format Online
Article
Text
id pubmed-8855204
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-88552042022-02-23 Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report Liu, Wen-Yu Zhang, Jia-Rong Xu, Xian-Ming Ye, Tian-Yi World J Clin Cases Case Report BACKGROUND: Preterm birth accounts for about 12% of all pregnancies worldwide and is the leading cause of neonatal morbidity and mortality. In order to avoid premature birth and prolong gestational age, tocolytics are the first and the best choice. Ritodrine is the most commonly used tocolytic medication. However, side effects such as pulmonary edema, hypokalemia, and hyperglycemia are known. Here we report a rare but serious side effect–toxic epidermal necrolysis (TEN)–caused by ritodrine. CASE SUMMARY: A woman (31 years, gravida 4, para 2) was hospitalized because of premature contractions at 27 + 6 wk of gestation. A skin rash with pruritus appeared at 32 + 3 wk of gestation after administration of ritodrine, indomethacin, and dexamethasone, and it spread throughout the whole body in 3 d, particularly the four limbs. After 11 d’ treatment, she was diagnosed with TEN. An emergency cesarean section was performed immediately to deliver the baby and intensive symptomatic treatment was promptly commenced after delivery. She recovered from the severe condition without any sequelae except for slight pigmentation after symptomatic treatment. CONCLUSION: When a skin rash appears during the administration of ritodrine, we are supposed to consider the risk of TEN. Baishideng Publishing Group Inc 2022-02-06 2022-02-06 /pmc/articles/PMC8855204/ /pubmed/35211573 http://dx.doi.org/10.12998/wjcc.v10.i4.1381 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Report
Liu, Wen-Yu
Zhang, Jia-Rong
Xu, Xian-Ming
Ye, Tian-Yi
Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
title Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
title_full Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
title_fullStr Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
title_full_unstemmed Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
title_short Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
title_sort toxic epidermal necrolysis induced by ritodrine in pregnancy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855204/
https://www.ncbi.nlm.nih.gov/pubmed/35211573
http://dx.doi.org/10.12998/wjcc.v10.i4.1381
work_keys_str_mv AT liuwenyu toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport
AT zhangjiarong toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport
AT xuxianming toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport
AT yetianyi toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport